Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

HUYA Bioscience partners with Chinese university

Sep. 9, 2011

Debiopharm and Ascenta Therapeutics announce exclusive license agreement for AT-406

Sep. 8, 2011

MediGene and Pharmanova enter agreement for Veregen

Sep. 7, 2011

Adolor completes reacquisition of all rights to alvimopan

Sep. 7, 2011

Evotec and Roche enter worldwide agreement for EVT-302

Sep. 6, 2011

AMT and NIH sign exclusive license agreement for AAV-5-based gene therapy vectors

Sep. 6, 2011

Astellas Pharma and Evec sign license agreement

Sep. 6, 2011

Addex Pharmaceuticals regains rights to metabotropic glutamate mGlu4 receptor PAM program

Sep. 5, 2011

Royal DSM and Sinochem establish global joint venture

Sep. 5, 2011

PTC Therapeutics and Genzyme restructure collaboration agreement for ataluren

Sep. 5, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...